Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Tiziana Life Sciences Ltd
TLSACurrent price
1.58 USD
+0.14 USD (+9.72%)
Last closed
1.37 USD
Company
www.tizianalifesciences.com
ISIN
BMG889121031
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
160 081 760 USD
Yield for 12 month
+71.93 %
1Y
3Y
5Y
10Y
15Y
TLSA
Tiziana Life Sciences Ltd, a biotechnology company, specializes in the development of transformative therapies for neurodegenerative and lung diseases in the United States. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, multiple sclerosis, type-1 diabetes, inflammatory bowel, psoriasis, and rheumatoid arthritis diseases. It also develops TZLS-501, a fully human mAb targeting the IL-6 receptor for the treatment of inflammatory and oncology indications. Tiziana Life Sciences Ltd was incorporated in 1998 and is headquartered in London, the United Kingdom. Address: 14/15 Conduit Street, London, United Kingdom, W1S 2XJ
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
3.00 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
-46 000 USD
Key Figures TLSA
1 year
3 years
5 years
10 years
EBITDA
-15 782 000 USD
Operating Margin TTM
Price to Earnings
–
Return On Assets TTM
-84.13 %
PEG Ratio
–
Return On Equity TTM
-250.49 %
Wall Street Target Price
3.00 USD
Revenue TTM
-3 595 000 USD
Book Value
0.035 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-0.11 USD
Diluted Eps TTM
-0.11 USD
Most Recent Quarter
II 2023
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics TLSA
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History TLSA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
–
Dividend CAGR 3Y
–
Dividend CAGR 5Y
–
Dividend CAGR 10Y
–
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
–
Forward Annual Dividend
– USD
Last Split Factor
2499:1000
Payout Ratio TTM
–
Last Split Date
31.07.2020
Stock Valuation TLSA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
-5.98
Price Book MRQ
42.16
Financials TLSA
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators TLSA
For 52 weeks
0.63 USD
1.91 USD
50 Day MA
1.24 USD
Shares Short Prior Month
1 047 523
200 Day MA
1.03 USD
Short Ratio
2.91
Shares Short
957 043
Short Percent
1.23 %
BeatStart